Should you buy Amgen after robust earnings take stock higher?

Should you buy Amgen after robust earnings take stock higher?

Amgen Inc. (NASDAQ:AMGN) has been robust lately. The stock established a strong support at the oversold level of $233 in early May. The main catalyst for the gains in Amgen stock has been its quarterly results which came better than expected. As Amgen reported its first-quarter 2022 results on April 27, analysts expected a $4.13
The post Should you buy Amgen after robust earnings take stock higher? appeared first on Invezz.